Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Interim Management Statement

19 May 2022 10:27

RNS Number : 1108M
Mandarin Oriental International Ltd
19 May 2022
Β 

Announcement

Β 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

Β 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

Β 

19th May 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2022.

Β 

Trading conditions in the period improved in most parts of the world compared to the first quarter of 2021. Government restrictions on international and domestic travel, however, hampered the operating performance in Asia, with properties in China being particularly affected, and these challenges have continued into the second quarter.

Β 

In Europe, Middle East and Africa ('EMEA') and America, occupancy levels were lower than pre-pandemic levels for most properties, but room rates have held up well and are generally higher than in 2019. In Asia, both occupancy and room rates have remained substantially below pre-pandemic levels.

Β 

During the first quarter, the Group announced three new properties, in the Maldives, Costa Navarino and Cairo, increasing the Group's pipeline of new hotels and residences under development to 25.

Β 

The Group recorded an EBITDA loss of US$1 million in the first quarter. The impact of continued travel restrictions in much of Asia was offset by a more robust performance in EMEA and America and tightly-controlled corporate costs. Owned hotels and the management business recorded an underlying EBITDA loss of US$6 million and an underlying EBITDA profit of US$5 million, respectively.

Β 

Underlying losses (unaudited) for the Group were much improved compared to 2021, with the management business recording a marginal underlying profit (unaudited) in the period. As noted in the Group's 2021 full year results in March 2022, the outlook continues to improve in most markets, but there remains uncertainty in relation to China.

Β 

The Group's financial position is robust. Net debt at 31st March 2022 was US$542 million, and the Group held US$159 million of cash reserves and US$317 million in available, committed debt facilities. Gearing was 11% of adjusted shareholders' funds.

Β 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

Β 

- end -

Β 

For further information, please contact:

Β 

Mandarin Oriental Hotel Group International Limited

James RileyΒ 

(852) 2895 9288

Matthew BishopΒ 

(852) 2895 9288

Brunswick Group Limited

Sunitha Chalam

(65) 6426 8188

Β 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DOCKKLBFLELLBBZ
Date   Source Headline
14th May 201812:08 pmRNSDirector/PDMR Shareholding
11th May 201810:12 amRNSDirector Declaration
9th May 20182:47 pmRNSDirectorate Change
9th May 20182:34 pmRNSNon-Routine Resolutions submitted via NSM
9th May 20182:19 pmRNSResult of AGM
9th May 201812:32 pmRNSInterim Management Statement
3rd May 201811:03 amRNSDirector/PDMR Shareholding
2nd May 201811:15 amRNSDirector/PDMR Shareholding
2nd May 201810:34 amRNSDividend
30th Apr 201810:54 amRNSTotal Voting Rights
25th Apr 201810:51 amRNSDirector/PDMR Shareholding
12th Apr 201810:49 amRNSAnnual Financial Report
29th Mar 201810:28 amRNSTotal Voting Rights
26th Mar 201810:34 amRNSBlock listing Interim Review
19th Mar 201811:11 amRNSDirector/PDMR Shareholding
14th Mar 20187:38 amRNSAdditional Listing
12th Mar 20189:16 amRNSDirector/PDMR Shareholding
8th Mar 20189:07 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
7th Feb 20189:14 amRNSNotice of 2017 Final Results
31st Jan 201810:33 amRNSTotal Voting Rights
16th Jan 201810:07 amRNSDirector/PDMR Shareholding
27th Dec 20179:39 amRNSDirector/PDMR Shareholding
21st Dec 201710:06 amRNSDirector/PDMR Shareholding
1st Dec 20179:58 amRNSDirector/PDMR Shareholding
30th Nov 20179:21 amRNSDirector/PDMR Shareholding
30th Nov 20179:17 amRNSTotal Voting Rights
31st Oct 20179:12 amRNSTotal Voting Rights
25th Oct 201711:15 amRNSDirector/PDMR Shareholding
4th Oct 201710:11 amRNSDividend
3rd Oct 201711:25 amRNSDirector/PDMR Shareholding
29th Sep 201711:09 amRNSDirector/PDMR Shareholding
27th Sep 20177:31 amRNSUpdate Review:Long-term Strategic Options for EXHK
25th Sep 201710:14 amRNSBlock listing Interim Review
15th Sep 201710:11 amRNSMO-Review of Long-term Strategic Options for EXHK
3rd Aug 201710:06 amRNSHalf Yearly Results
6th Jul 201710:15 amRNSNotice of 2017 Half-Yearly Results
5th Jun 20177:00 amRNSMO to Review Long-term Strategic Options for EXHK
3rd May 20172:13 pmRNSNon-Routine Resolutions submitted via NSM
3rd May 20172:01 pmRNSResult of AGM
3rd May 201712:35 pmRNSInterim Management Statement
28th Apr 201710:10 amRNSTotal Voting Rights
26th Apr 201710:40 amRNSDividend
5th Apr 201710:16 amRNSAnnual Financial Report
31st Mar 201710:42 amRNSTotal Voting Rights
27th Mar 201710:13 amRNSBlock listing Interim Review
27th Mar 201710:10 amRNSDirector/PDMR Shareholding
14th Mar 201711:04 amRNSDirector/PDMR Shareholding
3rd Mar 20178:06 amRNSAdditional Listing
2nd Mar 20179:06 amRNS2016 PRELIMINARY ANNOUNCEMENT OF RESULTS
1st Feb 20179:40 amRNSNotice of 2016 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.